These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22305682)

  • 1. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.
    Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC
    J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD.
    Chaudhuri R; McSharry C; Spears M; Brady J; Grierson C; Messow CM; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi O; Miller DK; Thomson NC
    Transl Respir Med; 2013 Dec; 1(1):11. PubMed ID: 27234393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
    Hao W; Li M; Zhang Y; Zhang C; Wang P
    Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
    Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
    Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum.
    LaPan P; Brady J; Grierson C; Fleming M; Miller D; Sypek J; Fu B
    BMC Pulm Med; 2010 Aug; 10():40. PubMed ID: 20678199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.
    Vignola AM; Paganin F; Capieu L; Scichilone N; Bellia M; Maakel L; Bellia V; Godard P; Bousquet J; Chanez P
    Eur Respir J; 2004 Dec; 24(6):910-7. PubMed ID: 15572531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
    Haq I; Lowrey GE; Kalsheker N; Johnson SR
    Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Concavity of the Maximal Expiratory Flow-Volume Curve Reflects the Extent of Emphysema in Obstructive Lung Diseases.
    Mochizuki F; Iijima H; Watanabe A; Tanabe N; Sato S; Shiigai M; Fujiwara K; Shimada T; Ishikawa H; Kanazawa J; Yatagai Y; Masuko H; Sakamoto T; Muro S; Hizawa N
    Sci Rep; 2019 Sep; 9(1):13159. PubMed ID: 31511572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
    Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC
    Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center study.
    Hartley RA; Barker BL; Newby C; Pakkal M; Baldi S; Kajekar R; Kay R; Laurencin M; Marshall RP; Sousa AR; Parmar H; Siddiqui S; Gupta S; Brightling CE
    J Allergy Clin Immunol; 2016 May; 137(5):1413-1422.e12. PubMed ID: 27006248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
    Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
    Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
    Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
    Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
    Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].
    Wu SM; Li CE; Cai RP; Zhang Q; Xu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):892-6. PubMed ID: 23328178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years.
    Miller M; Cho JY; Pham A; Friedman PJ; Ramsdell J; Broide DH
    Chest; 2011 Jun; 139(6):1380-1387. PubMed ID: 20966041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.